Is there racial/ethnic variance in cervical cancer- specific survival of older women in the united states?

L. Holmes, J. Hossain
{"title":"Is there racial/ethnic variance in cervical cancer- specific survival of older women in the united states?","authors":"L. Holmes, J. Hossain","doi":"10.4314/IJHR.V2I4.55428","DOIUrl":null,"url":null,"abstract":"Purpose: To examine racial/ethnic differences in cervical carcinoma survival of older US women, as well as the impact of income, cell type (tumor histology), tumor stage and treatment on survival of this cohort. Methods: A population-based cohort of women diagnosed with \nincident cervical carcinoma, between 1992 and 1999, in the Surveillance Epidemiology and End Results (SEER) Data was linked with Medicare to examine the impact of race/ethnicity on overall and cancer-specific survival, using Kaplan Meier survival estimates and multivariable Cox Regression model. Results: There was no significant racial/ethnic variation in overall and cervical cancer-specific survival. However, the advanced tumor \nstage at diagnosis, treatment received and advanced age at tumor diagnosis were the only significant predictors of survival. Compared with no surgery, there was a significant 66% decreased risk of dying from overall cause of death (adjusted hazard ratio, AHR = 0.34, 5% Confidence Interval, CI = 0.26-0.46), and significant 51% decreased risk of dying from cervical cancer-specific cause, AHR = 0.41, 95% CI, 0.28-0.58, for women who received radical surgery. There was a dose-response effect between tumor stage at diagnosis and survival. Relative to women who were diagnosed with stage I tumor (early stage), those who were diagnosed at stage IV (late stage) were almost three times as likely to die from overall cause (AHR = 2.78, 95% CI, 2.24 – 3.45), as well as two times as likely to die from cancer-specific cause, AHR = 2.28, 95% CI, 1.76 – 2.29. The risk of dying also significantly increased with advancing age. Conclusion: There was no racial/ethnic variance in overall and \ncervical cancer-specific survival among older US women but \nsurvival was significantly influenced by treatment received tumor stage at diagnosis and age at diagnosis. \n \nKeywords: Cervical carcinoma; Race/ethnicity; Income; \nHistopathology; Survival.","PeriodicalId":93450,"journal":{"name":"International journal of health research and innovation","volume":"30 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2010-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of health research and innovation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/IJHR.V2I4.55428","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To examine racial/ethnic differences in cervical carcinoma survival of older US women, as well as the impact of income, cell type (tumor histology), tumor stage and treatment on survival of this cohort. Methods: A population-based cohort of women diagnosed with incident cervical carcinoma, between 1992 and 1999, in the Surveillance Epidemiology and End Results (SEER) Data was linked with Medicare to examine the impact of race/ethnicity on overall and cancer-specific survival, using Kaplan Meier survival estimates and multivariable Cox Regression model. Results: There was no significant racial/ethnic variation in overall and cervical cancer-specific survival. However, the advanced tumor stage at diagnosis, treatment received and advanced age at tumor diagnosis were the only significant predictors of survival. Compared with no surgery, there was a significant 66% decreased risk of dying from overall cause of death (adjusted hazard ratio, AHR = 0.34, 5% Confidence Interval, CI = 0.26-0.46), and significant 51% decreased risk of dying from cervical cancer-specific cause, AHR = 0.41, 95% CI, 0.28-0.58, for women who received radical surgery. There was a dose-response effect between tumor stage at diagnosis and survival. Relative to women who were diagnosed with stage I tumor (early stage), those who were diagnosed at stage IV (late stage) were almost three times as likely to die from overall cause (AHR = 2.78, 95% CI, 2.24 – 3.45), as well as two times as likely to die from cancer-specific cause, AHR = 2.28, 95% CI, 1.76 – 2.29. The risk of dying also significantly increased with advancing age. Conclusion: There was no racial/ethnic variance in overall and cervical cancer-specific survival among older US women but survival was significantly influenced by treatment received tumor stage at diagnosis and age at diagnosis. Keywords: Cervical carcinoma; Race/ethnicity; Income; Histopathology; Survival.
美国老年妇女宫颈癌特异性生存率是否存在种族/民族差异?
目的:研究美国老年妇女宫颈癌生存的种族差异,以及收入、细胞类型(肿瘤组织学)、肿瘤分期和治疗对该队列生存的影响。方法:使用Kaplan Meier生存估计和多变量Cox回归模型,将1992年至1999年监测流行病学和最终结果(SEER)数据中诊断为偶发性宫颈癌的妇女的基于人群的队列与医疗保险相关联,以检查种族/民族对总体和癌症特异性生存的影响。结果:总体生存率和宫颈癌特异性生存率没有明显的种族/民族差异。然而,诊断时的肿瘤分期、接受的治疗和肿瘤诊断时的高龄是唯一显著的生存预测因素。与未接受手术相比,接受根治性手术的妇女因总死亡原因死亡的风险显著降低66%(校正风险比,AHR = 0.34, 5%置信区间,CI = 0.26-0.46),因宫颈癌特异性原因死亡的风险显著降低51%,AHR = 0.41, 95% CI, 0.28-0.58。诊断时肿瘤分期与生存期之间存在剂量-反应效应。相对于被诊断为I期肿瘤(早期)的妇女,被诊断为IV期(晚期)的妇女死于总体原因的可能性几乎是其三倍(AHR = 2.78, 95% CI, 2.24 - 3.45),死于癌症特异性原因的可能性是其两倍,AHR = 2.28, 95% CI, 1.76 - 2.29。随着年龄的增长,死亡的风险也显著增加。结论:美国老年妇女的总体生存率和宫颈癌特异性生存率没有种族/民族差异,但生存率受到所接受治疗的肿瘤诊断分期和诊断年龄的显著影响。关键词:宫颈癌;种族/民族;收入;组织病理学;生存。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信